CME Group Inc (NASDAQ: CME) has reported E.P.S. of $2.49 for its third fiscal quarter (ending September 30) versus $2.51 for the same period a year ago — a decline of -1%. Relative to the consensus estimate of $2.63, this was a shortfall of $-0.14. For the latest four quarters through September 30, E.P.S. were $10.33 compared to $9.53 a year ago — an increase of 8%.
Recent Price Action
On 10/22/25, CME Group Inc (NASDAQ: CME) stock declined slightly by -0.3%, closing at $267.81. NORMAL trading volume accompanied the decline. The stock has performed in line with the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
CME Group has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. CME Group has a poor Appreciation Score of 25 but a neutral Power Rating of 59, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment